This inventor holds 1 USPTO granted patent. Top assignee: Morphochem Gmbh. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Sven Nerdinger: Innovator in Factor Xa Inhibition
Introduction
Sven Nerdinger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit factor Xa activity. His work is crucial for advancing treatments for diseases mediated by this enzyme.
Latest Patents
Sven holds 1 patent related to his innovative work. His patent, titled "Compounds that inhibit factor Xa activity," describes compounds that can be used for the inhibition of Factor Xa and for the treatment and/or prevention of diseases that are mediated by Factor Xa activity. This invention represents a significant advancement in therapeutic options for patients.
Career Highlights
Sven is currently associated with Morphochem GmbH, a company focused on developing innovative pharmaceutical solutions. His role at Morphochem has allowed him to leverage his expertise in medicinal chemistry and contribute to groundbreaking research.
Collaborations
Sven collaborates with talented professionals in his field, including Thilo Fuchs and Katrin Illgen. These partnerships enhance the research and development efforts at Morphochem, fostering an environment of innovation and discovery.
Conclusion
Sven Nerdinger's contributions to the field of pharmaceuticals, particularly through his patent on factor Xa inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile